These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27693072)

  • 1. Acute Toxicity from Topical Cocaine for Epistaxis: Treatment with Labetalol.
    Richards JR; Laurin EG; Tabish N; Lange RA
    J Emerg Med; 2017 Mar; 52(3):311-313. PubMed ID: 27693072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cocaine cardiovascular toxicity: a systematic review.
    Richards JR; Garber D; Laurin EG; Albertson TE; Derlet RW; Amsterdam EA; Olson KR; Ramoska EA; Lange RA
    Clin Toxicol (Phila); 2016 Jun; 54(5):345-64. PubMed ID: 26919414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Blockers, Cocaine, and the Unopposed α-Stimulation Phenomenon.
    Richards JR; Hollander JE; Ramoska EA; Fareed FN; Sand IC; Izquierdo Gómez MM; Lange RA
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):239-249. PubMed ID: 28399647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial infarction associated with inappropriate use of topical cocaine as treatment for epistaxis.
    Ross GS; Bell J
    Am J Emerg Med; 1992 May; 10(3):219-22. PubMed ID: 1586432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol.
    Richards JR; Lange RA; Arnold TC; Horowitz BZ
    Am J Emerg Med; 2017 Mar; 35(3):519.e1-519.e4. PubMed ID: 27707569
    [No Abstract]   [Full Text] [Related]  

  • 6. Cocaine toxicity after laryngoscopy in an infant.
    Rezvani M; Hartfield D
    Can J Clin Pharmacol; 2006; 13(2):e232-5. PubMed ID: 16820655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans.
    Boehrer JD; Moliterno DJ; Willard JE; Hillis LD; Lange RA
    Am J Med; 1993 Jun; 94(6):608-10. PubMed ID: 8506886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labetalol and cardiovascular consequences of cocaine use.
    Richards JR; Lange RA
    Trends Cardiovasc Med; 2016 Feb; 26(2):202-3. PubMed ID: 26116092
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of topical tranexamic acid in the management of idiopathic anterior epistaxis in adult patients in the emergency department.
    Logan JK; Pantle H
    Am J Health Syst Pharm; 2016 Nov; 73(21):1755-1759. PubMed ID: 27769971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death temporally related to the use of a Beta adrenergic receptor antagonist in cocaine associated myocardial infarction.
    Fareed FN; Chan G; Hoffman RS
    J Med Toxicol; 2007 Dec; 3(4):169-72. PubMed ID: 18072171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison between topical anaesthesia with cocaine versus lidocaine plus adrenaline for outpatient laser dacryocystorhinostomy].
    Alañón F; Alañón MA; Jiménez JA; Calero B; Noriega A; Plaza G
    Arch Soc Esp Oftalmol; 2014 Feb; 89(2):53-7. PubMed ID: 24332687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should beta-blockers be used in the treatment of cocaine-associated acute coronary syndrome?
    Page RL; Utz KJ; Wolfel EE
    Ann Pharmacother; 2007 Dec; 41(12):2008-13. PubMed ID: 17956961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of labetalol, the first alpha- and beta-blocking agent.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of labetalol in the management of cocaine crisis.
    Gay GR; Loper KA
    Ann Emerg Med; 1988 Mar; 17(3):282-3. PubMed ID: 3345023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a randomized controlled trial.
    Zahed R; Moharamzadeh P; Alizadeharasi S; Ghasemi A; Saeedi M
    Am J Emerg Med; 2013 Sep; 31(9):1389-92. PubMed ID: 23911102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of labetalol on hemodynamic parameters and soluble biomarkers of inflammation in acute coronary syndrome in patients with active cocaine use.
    Hoskins MH; Leleiko RM; Ramos JJ; Sola S; Caneer PM; Khan BV
    J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):47-52. PubMed ID: 20133495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the R, R-isomer of labetalol, SCH 19927, in isolated tissues and in spontaneously hypertensive rats during a repeated treatment.
    Monopoli A; Bamonte F; Forlani A; Ongini E; Parravicini L
    Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):256-63. PubMed ID: 6151824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is topical tranexamic acid a better alternative for selected cases of anterior epistaxis management in the ED?
    Hassen GW; Clemons P; Kaplun M; Kalantari H
    Am J Emerg Med; 2018 Apr; 36(4):734.e1-734.e2. PubMed ID: 29310981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.
    Sybertz EJ; Sabin CS; Pula KK; Vliet GV; Glennon J; Gold EH; Baum T
    J Pharmacol Exp Ther; 1981 Aug; 218(2):435-43. PubMed ID: 6114171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous labetalol in hypertensive patients treated with beta-adrenoreceptor-blocking drugs.
    Pearson RM; Havard CW
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):795-8. PubMed ID: 10953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.